Pharmacological hyperprolactinaemia
You will be benefited from our expertise, collaborative R&D, and dedicated support team, ensuring a seamless and successful product development journey
Recalls & Warnings June 16, 2020 FDA Warns Four Companies for Unsafe "Homeopathic" Injectables On June 16, 2020, the FDA issued warning letters to four manufacturers of unapproved injectable drugs labeled as homeopathic
11453D) at a cell-to-bead ratio of 2.5:1 in RPMI 1640 medium (Gibco) supplemented with 10% fetal calf serum, 100 U ml 1 penicillin, 100 g ml 1 streptomycin and 50 M 2-mercaptoethanol, in the absence or presence of 1 mM L-histidine (Thermo Fisher Scientific, cat
Principal Investigator on An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants with Major Depressive Disorder (MDD). (Janssen)